HighTower Advisors’s Senti Biosciences Holdings SNTI Stock Holding History

HighTower Advisors’s Portfolio SNTI Stock Details SNTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,900	Closed	-$1.09M	–	3466
2021 Q3	$1.09M	Hold	10,900	–	–	﹤0.01%	1604
2021 Q2	$1.09M	Buy	+10,900	New	+$1.09M	﹤0.01%	1584

Other funds holding SNTI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

CIM

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

HighTower Advisors's SNTI Position: Q4 2021 in Review

HighTower Advisors sold out of Senti Biosciences Holdings (SNTI) in Q4 2021, closing a stake of 10,900 shares — an estimated $1.09M sold.

HighTower Advisors first reported a position in SNTI in Q2 2021 and held it in 2 quarters. The position peaked at $1.09M in Q3 2021. 42 funds tracked by Wall St. Rank hold SNTI as of Q4 2021.

HighTower Advisors reported no remaining Senti Biosciences Holdings position as of Q4 2021 after selling out during the quarter.
HighTower Advisors sold 10,900 Senti Biosciences Holdings shares in Q4 2021, an estimated $1.09M.
HighTower Advisors first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 2 quarters.
HighTower Advisors's Senti Biosciences Holdings position peaked at $1.09M in Q3 2021.
42 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q4 2021.

Based on HighTower Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.